These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29323859)

  • 21. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve.
    Portugal RD; Garnica M; Nucci M
    J Clin Oncol; 2009 Aug; 27(23):3849-54. PubMed ID: 19597026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-index: A New Scoring System in Febrile Neutropenic Patients for Predicting Invasive Fungal Infections.
    Yılmaz G; Coşkun B; Elhan A; Azap A; Akan H
    Turk J Haematol; 2016 Jun; 33(2):102-6. PubMed ID: 26376689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study.
    Bhardwaj PV; Emmich M; Knee A; Ali F; Walia R; Roychowdhury P; Clark J; Sridhar A; Lagu T; Loh KP
    Support Care Cancer; 2021 Oct; 29(10):5905-5914. PubMed ID: 33761002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors for poor prognosis febrile neutropenia.
    Ahn S; Lee YS
    Curr Opin Oncol; 2012 Jul; 24(4):376-80. PubMed ID: 22476191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.
    Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela Echaburu J; Sánchez Cánovas M; Ayala de la Peña F
    Clin Transl Oncol; 2017 Sep; 19(9):1084-1090. PubMed ID: 28289961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND; Gan GG; Adeeba K
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initial management of febrile neutropenia].
    Badertscher L; Damak H; Mercier L; Décosterd D
    Rev Med Suisse; 2016 Aug; 12(526):1321-1325. PubMed ID: 28671776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognosis prediction of febrile neutropenia by MASCC score: A retrospective study].
    Cervetti L; Vallard A; Le Moulec S; Espenel S; Falk AT; Ben Mrad M; Guy JB; Diao P; Méry B; Langrand-Escure J; Ferrand FR; Rivoirard R; Ceccaldi B; Védrine L; Magné N; Chargari C
    Bull Cancer; 2016 Jun; 103(6):561-70. PubMed ID: 27181759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia.
    Sütcüoğlu O; Akdoğan O; Gürler F; Kurt İnci B; Özdemir N; Özet A; Yazıcı O
    Int J Clin Pract; 2021 Jul; 75(7):e14185. PubMed ID: 33783936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?
    Efe İris N; Yıldırmak T; Gedik H; Şimşek F; Aydın D; Demirel N; Yokuş O
    Turk J Haematol; 2017 Jun; 34(2):167-173. PubMed ID: 27348760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Infections associated with hematologic diseases].
    Akiyama N
    Rinsho Ketsueki; 2014 Oct; 55(10):2208-20. PubMed ID: 25297789
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High and low-risk febrile neutropenic patients].
    Blot F; Nitenberg G
    Presse Med; 2004 Apr; 33(7):467-73. PubMed ID: 15105769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CISNE or MASCC, which predictor is really the weakest in febrile neutropenia?
    Carmona-Bayonas A; Jiménez-Fonseca P
    Eur J Intern Med; 2018 Apr; 50():e33-e34. PubMed ID: 29157884
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemophagocytic syndrome with febrile neutropenia after chemotherapy.
    Imataki O; Watanabe N; Matsuoka A; Uemura M
    Intern Med; 2014; 53(14):1585-6. PubMed ID: 25030580
    [No Abstract]   [Full Text] [Related]  

  • 37. An infant with chronic severe neutropenia.
    Bhat RY; Varma CP; Bhatt S
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24711472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sepsis in Children with Febrile Neutropenia.
    Mongkolrattanothai K; Dien Bard J
    J Appl Lab Med; 2019 Jan; 3(4):530-533. PubMed ID: 31639721
    [No Abstract]   [Full Text] [Related]  

  • 39. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?
    Gunderson CC; Farrell R; Dinh BC; Thomas ED; Vesely SK; Lauer JK; Kao L; Chopra S; McMeekin DS; Moore KN
    Gynecol Oncol; 2013 Sep; 130(3):411-5. PubMed ID: 23791827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on "Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis".
    Ghajari H; Sabour S
    Crit Rev Oncol Hematol; 2020 Nov; 155():103089. PubMed ID: 32927334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.